To investigate whether miR-370-3p can be used as a therapeutic tool increasing the efficacy of the standard anti-GBM treatment, we first investigated whether miRNA-370-3p affects the MGMT expression level and increases the sensitivity of GBM cells to temozolomide, as previously reported. Here, MGMT is linked to glioblastoma.